|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Net investment in real estate properties | ||||||||||||||||||||
| Investments in real estate debt and securities (includes $XX and $259,378 at fair value as of March 31, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Debt-related investments, held for sale | ||||||||||||||||||||
| Investments in unconsolidated joint venture partnerships (includes $XX and $77,703 at fair value as of March 31, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Debt-related investments, net | ||||||||||||||||||||
| Investment in available-for-sale securities, at fair value | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| DST Program Loans (includes $XX and $170,865 at fair value as of March 31, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Secured financings on debt-related investments | ||||||||||||||||||||
| Intangible lease liabilities, net | ||||||||||||||||||||
| Financing obligations, net (includes $XX and $2,126,267 at fair value as of March 31, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Distribution fees payable to affiliates | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| Redeemable equity (Notes 9 and 10) | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value per share—200,000 shares authorized, none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value per share (Note 8) | ||||||||||||||||||||
| Class T | ||||||||||||||||||||
| Class S | ||||||||||||||||||||
| Class D | ||||||||||||||||||||
| Class I | ||||||||||||||||||||
| Class E | ||||||||||||||||||||
| Total common stock, $0.01 par value per share (Note 8) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Distributions in excess of earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
